FTI Consulting appoints Andrew Ward

FTI Consulting, a life science and healthcare communications practice, has appointed a new managing director in the form of Andrew Ward.

Ward joins the group from the Financial Times, where he was the pharmaceuticals correspondent for almost three years, covering the business, finance, science and regulation of the global pharmaceuticals and medical equipment industries.

Ben Atwell, senior managing director and global head of life sciences and healthcare at FTI Consulting Strategic Communications, said: “Andrew was one of the sector’s most respected reporters during his time covering healthcare, and brings invaluable global perspective to our prestigious client base.

“We look forward to benefiting from his deep media experience and welcoming him to our global team of over 50 healthcare experts.”

In his new role, Ward will broaden and deepen FTI Consulting’s client base globally.

He said: “I am excited to be joining the best communications practice in the healthcare sector.

“It is a difficult decision to leave the FT after 18 fantastic years but the opportunity to help industries was too good to turn down.”